Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D002247:Carbon Isotopes; D002417:Cattle; D003331:Coronary Vessels / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D008954:Models, Biological; D009206:Myocardium / Q000201:enzymology; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D010759:Phosphorus Isotopes; D014316:Tritium; D014665:Vasodilator Agents / Q000494:pharmacology*
D002247:Carbon Isotopes; D010726:Phosphodiesterase Inhibitors; D010759:Phosphorus Isotopes; D014665:Vasodilator Agents; D014316:Tritium; D010208:Papaverine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D007545:Isoproterenol